MedPath

Estradiol, Progesterone and Endometrial Thickness in Frozen Euploid Embryo Transfer

Completed
Conditions
Infertility
Preimplantation Genetic Diagnosis/Screening
Miscarriage
Registration Number
NCT03395665
Lead Sponsor
Institut Universitari Dexeus
Brief Summary

The development and improvement in Preimplantation genetic diagnosis/screening (PGS) in association with the efficacy and security of vitrification and trophectoderm biopsy, more efficient stimulation schemes and laboratory improvements in culture and embryo selection have contributed to high success of the assisted reproductive technologies(ART). Transferring an euploid embryo avoids one of the main reasons of miscarriage and implantation failure ( Rubio et al, 22016) and overcomes one of the most important confounding factors. Usually, the transfer of euploid embryos is performed under standard hormone replacement therapy (HRT) and are referred to as FET-PGS cycles( Frozen embryo transfer). The study of FET-PGS cycles with the transfer of a single euploid blastocyst is the best model for evaluation of the impact of the endometrial preparation . Among factors influencing FET outcomes, patient's age, endometrial preparation, endometrium thickness, endometrial pattern, number and quality of embryos transferred , difficulty at ET, recently P4 have received more attention .

The importance of Progesterone (P4) in embryo implantation has been widely studied. P4 plays an important role in endometrial gland formation, embryonic implantation and pregnancy maintenance, both in natural and artificial cycles.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
299
Inclusion Criteria
  • Frozen embryo transfer (FET) of at least one single euploid embryo.
  • Estradiol > 75pg/ml.
  • Progesterone > 4 ng/ml.
  • Endometrial thickness between 6 mm and 18 mm.
Exclusion Criteria
  • Patients with FET of no diagnostic or mosaic embryos, or known uterine abnormality were excluded.
  • Natura cycle protocol.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Miscarriage rateAny pregnancy loss before week 20

Miscarriage was defined as a loss following a positive pregnancy test and/or detectable Gestational sac

Pregnancy rate6 weeks after transfer procedure
Live birth rateTen months after transfer procedure
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of Obstetrics, Gynaecology and Reproduction Instituto Universitario Dexeus

🇪🇸

Barcelona, Spain

© Copyright 2025. All Rights Reserved by MedPath